Skip to content

Efficacy and safety of ShankhaPrakshalana, a yogic technique versus polyethylene glycol solution for bowel preparation in colonoscopy: A non inferiority randomized controlled trial.

Efficacy and safety of ShankhaPrakshalana, a yogic technique versus polyethylene glycol solution for bowel preparation in colonoscopy: A non inferiority randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055846
Enrollment
250
Registered
2023-07-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K590- Constipation Health Condition 2: K579- Diverticular disease of intestine,part unspecified, without perforation or abscess Health Condition 3: K582- Mixed irritable bowel syndrome Health Condition 4: K928- Other specified diseases of the digestive system Health Condition 5: K598- Other specified functional intestinal disorders Health Condition 6: K528- Other specified noninfective gastroenteritis and colitis

Interventions

Intervention1: ShankhaPrakshalana -a yogic technique: Patient will be asked to perform ShankaPrakshalana which is a yogic technique,involving 5 asanas which are repeated 8 times and whole cycle is rep

Sponsors

Intramural Project No sponser
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Scheduled to undergo medically indicated colonoscopy 2. Willing to give informed consent for participation in the study

Exclusion criteria

Exclusion criteria: 1.Patients with comorbid conditions(DM, hypertension, chronic liver disease, acute or chronic heart failure, arrhythmic disorder, renal failure, dyselectrolytemia) 2.Suspected or previously diagnosed intestinal stricture of any etiology 3.Pregnant and lactating female 4.Past history of bowel resection or any abdominal surgery 5.Altered consiousness 6.Patients suffering from severe neurological disease 7.History of opiates/narcotics, anti-diarrheal medicines, oral iron supplementation, oral contrast for ct enterography use in the last 14 days before colonoscopy 8.History of allergic reaction to PEG or any adverse effect 9.Unable or unwilling to consume PEG solution 10.Unable to complete all the asanas of SP 11.Refusal to participate or inability to provide informed consents

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of ShankhaPrakshalana with split dose PEG preparation in bowel cleaning for colonoscopy by boston bowel preparation scaleTimepoint: At baseline

Secondary

MeasureTime frame
To compare the ADR and PDR of ShankhaPrakshalana with split dose PEGTimepoint: Within 1 week of procedure;To compare the safety of ShankhaPrakshalana with PEG by assessing the adverse events Timepoint: within 7 days of colonoscopy;To compare the tolerability and acceptability of ShankhaPrakshalana with split dose PEG preparartion for bowel preparation in colonoscopyTimepoint: By prevalidated questionnare filled by patient just before the colonoscopy

Countries

India

Contacts

Public ContactDr Mansi Chaudhary

AIIMS, Bhubaneswar

medgast_manas@aiimsbhubaneswar.edu.in9861278332

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026